Hypertension. Essential (primary) hypertension
Conditions
Interventions
Intervention 1: After stabilization in the Emergency Department of Rajaie Cardiovascular Medical and Research Center and obtaining written informed consent, participants will complete the demographic
Flashcards number 3 to 5 (lifestyle modification) in Week 2
and Flashcard Number 6 (importance of medication adherence and expected side effects) in the third week. Weekly follow-up telephone calls will be conducted to monitor progress, answer questions, and i
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Confirmed diagnosed essential Hypertension for at least 6 months Use of at least one Antihypertensive medication according to JNC8 guideline No history of psychological disorders or any use of psychiatric medications as reported by the participant or family caregivers. Having a smartphone with internet connectivity Literacy in reading and writing, along with the ability to use a smartphone Absence of pregnancy Absence of conditions such as acute renal, cardiac and respiratory failure based on their past medical history Absence of severe visual and auditory impairments
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life Score in the HTNQOL-42 Questionnaire. Timepoint: Quality of Life will be measured at baseline and 21 days after the intervention. Method of measurement: HTNQOL-42 (Hypertension Quality of Life -42) Questionnaire.;Medication Adherence Score in the Morisky Medication Adherence Scale (MMAS-8). Timepoint: The Medication Adherence Score will be measured at baseline and 21 days post-intervention. Method of measurement: Morisky Medication Adherence Scale (MMAS-8). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoud Rezaie
Iran University of Medical Sciences
Outcome results
None listed